- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PF-04950615 (RN316)
Total 1292 results
-
PfizerCompletedHypercholesterolemiaUnited States
-
PfizerCompletedHyperlipidemiaUnited States, Canada
-
PfizerCompletedHyperlipidemiaKorea, Republic of, United States, Australia, Germany, Poland, Canada, Italy, Hong Kong, Czech Republic
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States
-
PfizerCompletedMetabolic Diseases | Dyslipidemias | Lipid Metabolism Disorders | Hypercholesterolemia | HyperlipidemiasUnited States
-
PfizerCompletedHypercholesterolemiaUnited States
-
PfizerTerminatedCardiovascular DiseaseFinland, United States, Netherlands, Spain, Korea, Republic of, China, Israel, Belgium, Germany, Australia, Czechia, Taiwan, Denmark, United Kingdom, Hungary, Poland, France, Mexico, Turkey, Canada, New Zealand, Colombia, Switzerland, Irelan... and more
-
PfizerCompletedHyperlipidemiaFinland, Netherlands, United States, Canada, Sweden, Korea, Republic of, Singapore, Czechia, Poland, United Kingdom, Puerto Rico, Norway
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States, Canada
-
PfizerTerminatedCardiovascular DiseaseUnited States, Finland, Netherlands, Spain, Belgium, Germany, Czechia, Switzerland, Denmark, Australia, United Kingdom, Korea, Republic of, Hungary, Israel, Poland, Taiwan, Mexico, Turkey, Ireland, Canada, New Zealand, South Africa, Brazi... and more
-
PfizerCompletedHyperlipidemiaUnited States, Spain, Taiwan, United Kingdom, Canada, Mexico, France, Hungary, Lithuania, Colombia, Romania, Russian Federation
-
PfizerCompletedHeterozygous Familial HypercholesterolemiaCanada, Netherlands, United Kingdom, United States, Spain, Poland, Finland, Norway, South Africa, Italy, Bulgaria
-
PfizerCompletedHypercholesterolemiaJapan
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States, Canada
-
PfizerCompletedHypercholesterolemiaUnited States
-
Kadmon Corporation, LLCCompleted
-
University of California, San FranciscoPfizer; San Francisco General HospitalTerminatedCardiovascular Disease | DyslipidemiaUnited States
-
PfizerCompleted
-
University of FloridaCompletedGastrointestinal Symptoms | Stool Frequency | Gastrointestinal Transit TimeUnited States
-
PfizerCompleted
-
PfizerCompletedSchizophreniaUnited States
-
PfizerCompleted
-
PfizerCompleted
-
PfizerCompleted
-
PfizerCompleted
-
PfizerRecruitingAtopic DermatitisUnited States, Canada
-
PfizerWithdrawnRespiratory Tract Diseases | Bronchial Diseases | Lung Diseases, Obstructive | Asthma, Bronchial
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis With Liver FibrosisHong Kong, United States, Taiwan, Puerto Rico, China, Canada, Korea, Republic of, Bulgaria, Japan, India, Poland, Slovakia
-
PfizerCompletedHealthy ParticipantsUnited States
-
PfizerCompletedDiabetes Mellitus, Type 1United States
-
PfizerTerminated
-
PfizerCompletedHealthy ParticipantsNetherlands
-
PfizerCompleted
-
PfizerRecruitingPulmonary Arterial HypertensionUnited States
-
PfizerCompletedHealthy | Chronic Rhinosinusitis With Nasal Polyps | Atopic DermatitisUnited States
-
PfizerCompletedPsoriasisCanada, United States, Japan, Poland
-
PfizerCompleted
-
PfizerCompleted
-
PfizerWithdrawnPrimary Hyperlipidemia or Mixed DyslipidemiaChina
-
PfizerCompleted
-
PfizerCompleted
-
PfizerActive, not recruitingHealthy ParticipantsNetherlands
-
PfizerCompleted